Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
This paper introduces a simple futility design that allows a comparative clinical trial to be stopped due to lack of effect at any of a series of planned interim analyses. Stopping due to apparent benefit is not permitted. The design is for use when any positive claim should be based on the maximum sample size, for example to allow subgroup analyses or the evaluation of safety or secondary efficacy responses. A final frequentist analysis can be performed that is valid for the type of design employed. Here the design is described and its properties are presented. Its advantages and disadvantages relative to the use of stochastic curtailment are discussed.
Whitehead
John
J
Medical and Pharmaceutical Statistics Research Unit, The University of Reading, Reading, UK. j.r.whitehead@reading.ac.uk
Matsushita
Tatsuru
T
D003627:Data Interpretation, Statistical; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy; D006801:Humans; D009716:Numerical Analysis, Computer-Assisted; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012107:Research Design; D018401:Sample Size; D013269:Stochastic Processes; D016896:Treatment Outcome